Retrophin jumps on Phase II FSGS data

Retrophin Inc. (NASDAQ:RTRX) rose $4.49 (28%) to $20.81 on Wednesday after it said combined data from the three cohorts of the Phase II

Read the full 230 word article

How to gain access

Continue reading with a
two-week free trial.